PIM3
Basic information
Region (hg38): 22:49960768-49964072
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PIM3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 22 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 0 | 4 |
Variants in PIM3
This is a list of pathogenic ClinVar variants found in the PIM3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-49960975-G-T | not specified | Uncertain significance (Feb 12, 2025) | ||
22-49960988-G-A | not specified | Uncertain significance (Oct 29, 2024) | ||
22-49961024-T-C | not specified | Uncertain significance (May 15, 2024) | ||
22-49961135-C-G | Benign (Nov 20, 2018) | |||
22-49961208-G-A | not specified | Uncertain significance (Jun 06, 2022) | ||
22-49961497-G-C | not specified | Uncertain significance (Nov 15, 2024) | ||
22-49961505-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
22-49961511-G-A | not specified | Uncertain significance (Dec 13, 2024) | ||
22-49961518-G-A | not specified | Uncertain significance (Mar 23, 2023) | ||
22-49961544-G-T | not specified | Uncertain significance (Dec 12, 2023) | ||
22-49961622-G-A | not specified | Uncertain significance (Jan 20, 2023) | ||
22-49961628-C-G | not specified | Uncertain significance (Apr 07, 2023) | ||
22-49961681-C-G | not specified | Uncertain significance (Sep 26, 2023) | ||
22-49961694-G-T | not specified | Uncertain significance (May 18, 2023) | ||
22-49961704-A-G | not specified | Uncertain significance (Sep 26, 2022) | ||
22-49961737-G-C | not specified | Uncertain significance (Dec 17, 2023) | ||
22-49961805-T-C | not specified | Uncertain significance (Dec 14, 2021) | ||
22-49962738-C-T | Benign (Nov 20, 2018) | |||
22-49962817-G-A | not specified | Uncertain significance (Feb 07, 2023) | ||
22-49962818-A-C | not specified | Uncertain significance (Jan 29, 2024) | ||
22-49962836-G-T | not specified | Uncertain significance (Jan 21, 2025) | ||
22-49962848-G-A | not specified | Uncertain significance (Dec 09, 2024) | ||
22-49962960-T-G | not specified | Uncertain significance (Nov 08, 2021) | ||
22-49963045-T-C | Benign (Jul 13, 2018) | |||
22-49963051-A-C | not specified | Uncertain significance (Nov 09, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PIM3 | protein_coding | protein_coding | ENST00000360612 | 6 | 3568 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.982 | 0.0181 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.922 | 151 | 186 | 0.810 | 0.0000110 | 2036 |
Missense in Polyphen | 20 | 58.441 | 0.34223 | 679 | ||
Synonymous | -4.54 | 139 | 85.5 | 1.62 | 0.00000528 | 680 |
Loss of Function | 3.24 | 0 | 12.2 | 0.00 | 6.30e-7 | 133 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Proto-oncogene with serine/threonine kinase activity that can prevent apoptosis, promote cell survival and protein translation. May contribute to tumorigenesis through: the delivery of survival signaling through phosphorylation of BAD which induces release of the anti-apoptotic protein Bcl-X(L), the regulation of cell cycle progression, protein synthesis and by regulation of MYC transcriptional activity. Additionally to this role on tumorigenesis, can also negatively regulate insulin secretion by inhibiting the activation of MAPK1/3 (ERK1/2), through SOCS6. Involved also in the control of energy metabolism and regulation of AMPK activity in modulating MYC and PPARGC1A protein levels and cell growth. {ECO:0000269|PubMed:15540201, ECO:0000269|PubMed:16818649, ECO:0000269|PubMed:17270021, ECO:0000269|PubMed:17876606, ECO:0000269|PubMed:18593906}.;
Recessive Scores
- pRec
- 0.154
Haploinsufficiency Scores
- pHI
- 0.232
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.401
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.857
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pim3
- Phenotype
- growth/size/body region phenotype; immune system phenotype; hematopoietic system phenotype; normal phenotype;
Gene ontology
- Biological process
- protein phosphorylation;apoptotic process;cell cycle;regulation of mitotic cell cycle;negative regulation of apoptotic process;protein autophosphorylation;negative regulation of insulin secretion involved in cellular response to glucose stimulus
- Cellular component
- cytoplasm;cytosol
- Molecular function
- protein serine/threonine kinase activity;protein binding;ATP binding